Close Menu

NEW YORK – Thermo Fisher Scientific said on Thursday that on April 17, it entered into a bridge credit agreement with JPMorgan Chase and Morgan Stanley Senior Funding for up to €9.25 billion ($9.96 billion).

The company had announced on March 3 that the lenders had committed to the debt financing in connection with its proposed acquisition of Qiagen.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.